Homolak, J. i Kodvanj, I. (2020). Widely available lysosome targeting agents should be considered as potential therapy for COVID-19. International Journal of Antimicrobial Agents, 56. (2). doi: 10.1016/j.ijantimicag.2020.106044
Homolak, Jan i Ivan Kodvanj. "Widely available lysosome targeting agents should be considered as potential therapy for COVID-19." International Journal of Antimicrobial Agents, vol. 56, br. 2, 2020. https://doi.org/10.1016/j.ijantimicag.2020.106044
Homolak, Jan i Ivan Kodvanj. "Widely available lysosome targeting agents should be considered as potential therapy for COVID-19." International Journal of Antimicrobial Agents 56, br. 2 (2020). https://doi.org/10.1016/j.ijantimicag.2020.106044
Homolak, J. i Kodvanj, I. (2020) 'Widely available lysosome targeting agents should be considered as potential therapy for COVID-19', International Journal of Antimicrobial Agents, 56(2). doi: 10.1016/j.ijantimicag.2020.106044
Homolak J, Kodvanj I. Widely available lysosome targeting agents should be considered as potential therapy for COVID-19. International Journal of Antimicrobial Agents [Internet]. 08.2020. [pristupljeno 30.08.2024.];56(2). doi: 10.1016/j.ijantimicag.2020.106044
J. Homolak i I. Kodvanj, "Widely available lysosome targeting agents should be considered as potential therapy for COVID-19", International Journal of Antimicrobial Agents, vol. 56, br. 2, Kolovoz 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:050587. [Citirano: 30.08.2024.]